Stock News

Dynavax Technologies (DVAX) Reaches $18.20 After 4.00% Down Move; 5 Analysts Bullish Immersion (IMMR)

Immersion Corporation (NASDAQ:IMMR) Logo

Among 5 analysts covering Immersion (NASDAQ:IMMR), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Immersion had 11 analyst reports since August 6, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, January 16 by Craig Hallum. The firm earned “Buy” rating on Monday, January 29 by Craig Hallum. The rating was downgraded by Zacks on Thursday, August 6 to “Buy”. The stock of Immersion Corporation (NASDAQ:IMMR) has “Buy” rating given on Friday, February 23 by Craig Hallum. The firm has “Buy” rating by FBR Capital given on Friday, February 23. Craig Hallum maintained it with “Buy” rating and $10 target in Friday, May 6 report. The firm has “Hold” rating given on Thursday, August 27 by TheStreet. The firm has “Buy” rating by Cowen & Co given on Wednesday, August 2. The stock has “Buy” rating by Lake Street on Monday, April 18. See Immersion Corporation (NASDAQ:IMMR) latest ratings:

23/02/2018 Broker: Craig Hallum Rating: Buy New Target: $17.0 Maintain
23/02/2018 Broker: FBR Capital Rating: Buy New Target: $18.0 Maintain
29/01/2018 Broker: Craig Hallum Rating: Buy New Target: $15.0 Maintain
16/01/2018 Broker: Craig Hallum Rating: Buy New Target: $12.0 Upgrade
30/11/2017 Broker: FBR Capital Rating: Buy New Target: $9.75
30/10/2017 Broker: B. Riley & Co Rating: Buy New Target: $9.75

The stock of Dynavax Technologies Corporation (NASDAQ:DVAX) is a huge mover today! The stock decreased 2.67% or $0.5 during the last trading session, reaching $18.2. About 423,998 shares traded. Dynavax Technologies Corporation (NASDAQ:DVAX) has risen 231.67% since April 20, 2017 and is uptrending. It has outperformed by 220.12% the S&P500.The move comes after 8 months negative chart setup for the $1.12 billion company. It was reported on Apr, 20 by Barchart.com. We have $17.47 PT which if reached, will make NASDAQ:DVAX worth $44.92M less.

Dynavax Technologies Corporation, a clinical-stage immunotherapy company, focuses on leveraging the power of the bodyÂ’s innate and adaptive immune responses through toll-like receptor stimulation. The company has market cap of $1.12 billion. The Company’s product candidates are being investigated for use in multiple cancer indications, as a vaccine for the prevention of hepatitis B and as a disease modifying therapy for asthma. It currently has negative earnings. The companyÂ’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine, which is in Phase III clinical trials; and SD-101, an investigational cancer immunotherapeutic that is in Phase I/II studies.

Investors sentiment decreased to 1 in Q4 2017. Its down 1.06, from 2.06 in 2017Q3. It dropped, as 15 investors sold Dynavax Technologies Corporation shares while 43 reduced holdings. 31 funds opened positions while 27 raised stakes. 43.53 million shares or 3.88% more from 41.91 million shares in 2017Q3 were reported. Bain Public Equity Management Ltd Llc, Massachusetts-based fund reported 249,052 shares. Earnest Ptnrs Lc stated it has 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Susquehanna Gru Ltd Liability Partnership owns 187,096 shares. Rhumbline Advisers holds 0% or 62,656 shares. Barclays Public Limited Com reported 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). 86,190 were accumulated by Credit Suisse Ag. Artal Group Incorporated holds 200,000 shares or 0.06% of its portfolio. State Board Of Administration Of Florida Retirement Systems has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). California-based Schwab Charles Investment has invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). 5,186 were reported by Ameritas Invest Prtn. Assetmark Inc invested 0% in Dynavax Technologies Corporation (NASDAQ:DVAX). Vantage Invest Advisors Ltd Company holds 0% or 500 shares in its portfolio. First L P has invested 0% of its portfolio in Dynavax Technologies Corporation (NASDAQ:DVAX). Metropolitan Life Ins Ny holds 0% or 19,450 shares. Swiss Bank & Trust has 0% invested in Dynavax Technologies Corporation (NASDAQ:DVAX) for 99,878 shares.

Among 6 analysts covering Dynavax Technologies (NASDAQ:DVAX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Dynavax Technologies had 27 analyst reports since August 12, 2015 according to SRatingsIntel. The rating was initiated by RBC Capital Markets with “Outperform” on Monday, November 30. The rating was maintained by William Blair with “Buy” on Monday, July 31. As per Thursday, November 9, the company rating was maintained by Cantor Fitzgerald. The stock of Dynavax Technologies Corporation (NASDAQ:DVAX) has “Outperform” rating given on Monday, July 31 by RBC Capital Markets. RBC Capital Markets maintained the stock with “Buy” rating in Sunday, October 29 report. The firm earned “Hold” rating on Wednesday, February 14 by J.P. Morgan. J.P. Morgan upgraded Dynavax Technologies Corporation (NASDAQ:DVAX) on Monday, July 31 to “Buy” rating. The firm has “Buy” rating given on Friday, September 1 by RBC Capital Markets. The stock has “Neutral” rating by JP Morgan on Wednesday, February 14. The firm has “Buy” rating by William Blair given on Friday, July 21.

Since December 13, 2017, it had 0 insider purchases, and 5 selling transactions for $1.07 million activity. Novack David F also sold $38,111 worth of Dynavax Technologies Corporation (NASDAQ:DVAX) on Friday, March 9. COFFMAN ROBERT sold $141,750 worth of stock or 7,500 shares. On Thursday, January 4 the insider Johnson David Louis sold $57,511.

Analysts await Dynavax Technologies Corporation (NASDAQ:DVAX) to report earnings on May, 14. They expect $-0.51 EPS, up 8.93% or $0.05 from last year’s $-0.56 per share. After $-0.43 actual EPS reported by Dynavax Technologies Corporation for the previous quarter, Wall Street now forecasts 18.60% negative EPS growth.

The stock decreased 0.17% or $0.02 during the last trading session, reaching $11.71. About 62,556 shares traded. Immersion Corporation (NASDAQ:IMMR) has risen 40.28% since April 20, 2017 and is uptrending. It has outperformed by 28.73% the S&P500.

Investors sentiment decreased to 0.79 in Q4 2017. Its down 0.46, from 1.25 in 2017Q3. It turned negative, as 12 investors sold Immersion Corporation shares while 27 reduced holdings. 15 funds opened positions while 16 raised stakes. 20.95 million shares or 0.68% more from 20.81 million shares in 2017Q3 were reported. Tiaa Cref Investment Management Limited Liability Co holds 74,407 shares. Bluefin Trading Limited Liability Corporation owns 30,458 shares for 0.01% of their portfolio. Morgan Stanley accumulated 108,156 shares. New York-based Jpmorgan Chase & has invested 0% in Immersion Corporation (NASDAQ:IMMR). Reilly Fin Ltd Co holds 0% or 1,000 shares. Prtnrs Lc reported 98,900 shares stake. Geode Mgmt Ltd Limited Liability Company holds 0% in Immersion Corporation (NASDAQ:IMMR) or 267,089 shares. Shannon River Fund Mngmt Limited has invested 1.56% in Immersion Corporation (NASDAQ:IMMR). Blackrock reported 0% of its portfolio in Immersion Corporation (NASDAQ:IMMR). Voya Investment Mngmt Lc invested 0% of its portfolio in Immersion Corporation (NASDAQ:IMMR). Fuller & Thaler Asset Mngmt reported 0.02% stake. Ny State Common Retirement Fund accumulated 25,600 shares or 0% of the stock. Tower Capital Ltd Liability (Trc) reported 22,278 shares. 64,017 are owned by Deutsche State Bank Ag. Walleye Trading Ltd Liability reported 69,834 shares or 0% of all its holdings.

Immersion Corporation (NASDAQ:IMMR) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *